Visit the original URL
The National Development and Reform Commission issued the “14th Five-Year Plan for Bioeconomic Development”. The plan proposes to give full play to the role of the National Emerging Industry Venture Capital Guidance Fund and the Strategic Emerging Industry Fund, and vigorously support the development of innovative biotechnology enterprises in accordance with the principle of marketization. Encourage social capital to gather, and use angel investment, venture capital, and foreign capital to solve the funds needed for enterprise R&D and production. Strengthen the listing and cultivation of biological enterprises, further increase the support for the listing of biological enterprises in the domestic capital market, and attract high-quality biological enterprises to be listed on the main board and the Science and Technology Innovation Board. Encourage government financing guarantee institutions to provide financing credit enhancement support for eligible small and medium bio-enterprises. Support banks to develop more credit products that are compatible with the characteristics of the bioeconomy. (Securities Times)
media coverage
36Kr i dark horse billion euro
Related events
- Development and Reform Commission: Further increase support for the listing of biological enterprises in the domestic capital market2022-05-10
- Xianweida completed 450 million yuan in Series C financing, led by IDG Capital2021-10-12
- Highgrade Biotech completed USD 75 million in Series D financing to accelerate the advancement of innovative pipeline varieties2021-06-15
- Chen’an Biotech completed 70 million yuan in Series B financing2020-06-24
- “Chen’an Bio” announced the completion of the A+ round of financing, BV Baidu Venture Capital invested 2019-09-05
This article is reprinted from: https://readhub.cn/topic/8fTEN8KpcVU
This site is for inclusion only, and the copyright belongs to the original author.